Please assess the completion status of the following clinical trial:

Trial Title: Gent for Pharyngeal Gonorrhea (GC)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Persons diagnosed with pharyngeal gonorrhea who are not yet treated~Exclusion Criteria:~* Age less than 16 years~* Receipt of antibiotics in ≤30 days~* Known allergy to any aminoglycoside~* History of renal disease (including diagnosis of solitary kidney, chronic renal insufficiency, renal cell carcinoma etc),~* Use of concurrent nephrotoxic drugs or muscle relaxants~* History of diabetes~* History of hearing loss or tinnitus~* Concurrent infection with syphilis or chlamydia~* Pregnancy and/or nursing~* Unable to return for a follow-up visit 4-7 days (+/- 1 day).~* Study team's discretion

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single Arm (Type: EXPERIMENTAL): Men who have sex with men (MSM) with pharyngeal gonorrhea will be treated with 360mg intramuscular gentamicin x 1.

Based on this trial design, predict the completion outcome and termination type (if applicable).